Prolonged Oral Vancomycin for Secondary Prophylaxis of Relapsing Clostridium Difficile Infection

BMC Infectious Diseases - United Kingdom
doi 10.1186/s12879-019-3676-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Vancomycin Enema in the Treatment of Clostridium Difficile Infection

Surgical Infections
SurgeryInfectious DiseasesMicrobiology
2019English

Cost-Effectiveness Analysis Evaluating Fidaxomicin Versus Oral Vancomycin for the Treatment of Clostridium Difficile Infection in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Clostridium Difficile Infection

Nature Reviews Disease Primers
Medicine
2016English

Clostridium Difficile Infection

Nature Reviews Disease Primers
Medicine
2016English

Clostridium Difficile Infection

Inflammatory Bowel Diseases
AllergyImmunologyGastroenterology
2016English

Both Oral Metronidazole and Oral Vancomycin Promote Persistent Overgrowth of Vancomycin-Resistant Enterococci During Treatment of Clostridium Difficile-Associated Disease

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2008English

The Difficile in Clostridium Difficile Infection

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2018English

Economic Evaluation of Fidaxomicin Compared With Vancomycin in the Treatment of Clostridium Difficile Infection

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Epidemiology of Clostridium Difficile Infection

Journal of Pharmacy Practice
PharmacologyPharmacy
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy